Robert Bondi, Eli Lily

Robert Bondi is a Senior Director in the Discovery PKPD Modeling group at Eli Lilly, where he supports drug discovery from target selection through first‑in‑human studies. He has over eleven years of experience in the pharmaceutical industry, including nine years specializing in PBPK and PKPD modeling to inform critical discovery decisions. His work spans a broad range of therapeutic modalities, including small molecules, antibody–drug conjugates, radioligand therapies, and protein degraders.